Cargando…
Evidence for a Cyanine Link Between Propargylamine Drugs and Monoamine Oxidase Clarifies the Inactivation Mechanism
Successful propargylamine drugs such as deprenyl inactivate monoamine oxidase (MAO), a target in multi-faceted approaches to prevent neurodegeneration in the aging population, but the chemical structure and mechanism of the irreversible inhibition are still debated. We characterized the covalent cya...
Autores principales: | Albreht, Alen, Vovk, Irena, Mavri, Janez, Marco-Contelles, Jose, Ramsay, Rona R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985292/ https://www.ncbi.nlm.nih.gov/pubmed/29892597 http://dx.doi.org/10.3389/fchem.2018.00169 |
Ejemplares similares
-
Parameters for Irreversible Inactivation of Monoamine Oxidase
por: Ramsay, Rona R., et al.
Publicado: (2020) -
Computational Insights into β-Carboline Inhibition of Monoamine Oxidase A
por: Prah, Alja, et al.
Publicado: (2022) -
ASS234, As a New Multi-Target Directed Propargylamine for Alzheimer's Disease Therapy
por: Marco-Contelles, José, et al.
Publicado: (2016) -
Why Monoamine Oxidase B Preferably Metabolizes N-Methylhistamine over Histamine: Evidence from the Multiscale Simulation of the Rate-Limiting Step
por: Maršavelski, Aleksandra, et al.
Publicado: (2022) -
COVID-19 infection and neurodegeneration: Computational evidence for interactions between the SARS-CoV-2 spike protein and monoamine oxidase enzymes
por: Hok, Lucija, et al.
Publicado: (2022)